COMMUNIQUÉS West-GlobeNewswire

Progressive Care Inc. Officially Moves to Newly Purchased Building
04/04/2019
MIAMI, April 04, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, announced today that it will be moving [...]
Tower One Secures Financing for 150 Towers
04/04/2019
VANCOUVER, British Columbia, April 04, 2019 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) announced today it has entered into a development [...]
IntelGenx Presents at 14th International Conference on Alzheimer’s and Parkinson’s Disease
04/04/2019
SAINT LAURENT, Quebec, April 04, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced its two Montelukast poster presentations received [...]
Blueberries Medical Commences Formal Development Process for the Cultivation of Cannabis in Jujuy Argentina
04/04/2019
TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American focused licensed producer of medicinal cannabis and [...]
ISRACANN Biosciences: Invest in Israel’s First Cannabis Pure-Play Public Offering -- CFN Media
04/04/2019
Seattle, Washington, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
Joseph J. Galligan Appointed as Senior Advisor to BioCorRx Inc.
04/04/2019
ANAHEIM, CA, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related [...]
Tonix Pharmaceuticals Plans to Expand TNX-102 SL Phase 3 Program Beyond PTSD to Include Fibromyalgia
04/04/2019
Encouraging FDA Meeting Minutes Support Phase 3 Development of TNX-102 SL 5.6 mg in Fibromyalgia NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a [...]
RTI Surgical® Applauds Blue Cross and Blue Shield of Alabama’s Positive Coverage Decision for Minimally Invasive Sacroiliac Joint Fusion Surgery
04/04/2019
Decision may help more patients access RTI’s SImmetry ® Sacroiliac Joint Fusion System, a minimally invasive surgical solution for sacroiliac (SI) joint dysfunction Blue Cross and Blue Shield of Alabama is the largest [...]
Theratechnologies Announces Financial Results for the First Quarter of 2019
04/04/2019
MONTREAL, April 04, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the first quarter ended February 28, 2019. First quarter 2019 financial [...]
Theratechnologies annonce ses résultats financiers pour le premier trimestre de 2019
04/04/2019
MONTRÉAL, 04 avr. 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX : TH) a annoncé aujourd’hui ses résultats financiers pour le premier trimestre clos le 28 février 2019. Faits saillants [...]
Aleafia Health Appoints Lead Independent Director
04/04/2019
TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) has appointed Loreto Grimaldi as the Lead Independent Director of the Company’s [...]
Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership
04/04/2019
BRACAnalysis CDx® Test Will Be Used to Identify Germline BRCA Mutations in Men with Metastatic Castrate-Resistant Prostate Cancer SALT LAKE CITY, April 04, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN [...]
Managers’ transactions
04/04/2019
Company announcement No. 6/2019 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 About Chr. Hansen [...]
Ogilvy Health Hires Industry Veteran Dan Chichester as Chief Experience Officer
04/04/2019
PARSIPPANY, N.J., April 04, 2019 (GLOBE NEWSWIRE) -- Ogilvy Health, part of The Ogilvy Group ( www.ogilvy.com ), today announced Dan Chichester has re-joined the network following a five-year hiatus, returning in the [...]
Algernon Pharmaceuticals Appoints Leading Inflammatory Bowel Disease Expert Dr. Walter Reinisch to Its Medical and Scientific Advisory Board
04/04/2019
VANCOUVER, British Columbia, April 04, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development [...]
Intercept to Present Results from the First Successful Phase 3 Trial in Patients with Liver Fibrosis Due to NASH at the International Liver Congress™ 2019
04/04/2019
Multiple additional abstracts evaluating obeticholic acid (OCA) for the treatment of patients with progressive non-viral liver diseases to be presented at the meeting NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- [...]
Homology Medicines Announces FDA Clearance of Investigational New Drug Application for HMI-102 Gene Therapy Candidate for PKU
04/04/2019
- Phase 1/2 pheNIX Trial Would Represent First PKU Gene Therapy to Enter the Clinic - - Initial Clinical Data Expected by the End of 2019 - BEDFORD, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. ( [...]
ContraFect Announces Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
04/04/2019
Vance G. Fowler, M.D., Professor of Medicine in the Division of Infectious Diseases, Duke University to Present New Data from the Exebacase Phase 2 Study YONKERS, New York, April 04, 2019 (GLOBE NEWSWIRE) -- ContraFect [...]
RedHill Biopharma to Present at Three Conferences in April
04/04/2019
TEL-AVIV, Israel and RALEIGH, N.C., April 04, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Pages